about
Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic reviewA survey of current trends in computational drug repositioningSpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA DataSystems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer.miRnalyze: an interactive database linking tool to unlock intuitive microRNA regulation of cell signaling pathways.The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associationsDeciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis.Analysis for the mechanism between the small cell lung cancer and non-small cell lung cancer combing the miRNA and mRNA expression profiles.Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell linesMicroRNAs as key regulators of xenobiotic biotransformation and drug response.Recent studies of 5-fluorouracil resistance in pancreatic cancermiRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysisWhole genome sequencing as a means to assess pathogenic mutations in medical genetics and cancer.miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.miRNAs target databases: developmental methods and target identification techniques with functional annotations.The cross talk between long, non-coding RNAs and microRNAs in gastric cancer.Current status on microRNAs as biomarkers for ovarian cancer.A Computational Systems Biology Approach for Identifying Candidate Drugs for Repositioning for Cardiovascular Disease.MicroRNAs, Regulatory Networks, and Comorbidities: Decoding Complex Systems.Role of micro-RNAs in drug resistance of multiple myeloma.A compilation of Web-based research tools for miRNA analysis.Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance.Analysis of population-specific pharmacogenomic variants using next-generation sequencing data.Overexpression of Exportin-5 Overrides the Inhibitory Effect of miRNAs Regulation Control and Stabilize Proteins via Posttranslation Modifications in Prostate Cancer.Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer.MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action.A novel miRNA analysis framework to analyze differential biological networks.MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells.Genome-wide miRNAs expression profiles of Schistosoma japonicum schistosomula in response to artesunate.Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish populationThe Network of Non-coding RNAs in Cancer Drug Resistance
P2860
Q26746063-F28B5055-259E-4386-9786-13629493D2DCQ28602324-CD962B3E-7F6E-4C26-9FBE-BBE8B0CAABC9Q31157753-F6F49BB9-707B-40D2-A0CE-23FA46676EFFQ33556004-A4685541-56D8-4AE9-A1FA-40201D9914ECQ33787523-15CC1CAC-003C-460F-9E5D-105CEAC266DFQ34248775-17827C19-4C87-4F3A-8955-C331E1A6F812Q34636525-AB21E87D-8085-4F0C-BAFC-B148EA44BF71Q35663529-3750EA6F-2801-4B6E-88C1-68BB3599790FQ36035933-DE3B65CC-F771-413E-8F32-A0054B16CDA2Q37165815-E990AC8A-7177-4A72-A1F9-AA1B92F1F9E4Q38235604-8FD38ADA-F61D-4682-BF88-850D35E4941AQ38268619-6971EFB2-EC6D-44DB-A25F-E8B58E003063Q38292741-D4B20028-7A98-4DEC-885C-1F026AFC3D8BQ38303683-9D860455-C959-48FD-8AF8-DB2980892B1BQ38366731-98A49C5C-A168-4016-AACF-3FC771EBD5F8Q38379632-F2AA958A-F8F4-4DBE-B634-A28443F66238Q38436885-84FF59D8-A82C-4C63-9FE1-895848E7C9D5Q38654296-468917CC-F009-4CC3-BF68-062A7E07E08FQ38711390-9F848CE1-0382-433A-8C3E-3BEEE8B95D7CQ38737353-D1B8956D-273B-4D46-A105-2F983B2043D1Q38821605-FADFF803-8DD7-49FE-91B8-A5568FC9A07AQ38919670-3F81C3EC-F9C0-4C43-A62F-6E3E4B046F5EQ39196049-1684BF8B-C52A-4CD6-8BD5-1332B4372AD3Q39379624-C2398F99-D603-456C-8558-B50EF06CB437Q41126784-7D293FAE-2E9D-48B3-AFEC-8D6D5945EA48Q41606948-4F1C6842-2170-4EB6-A7E9-D009C6A52876Q41623442-6AB0B75C-97A9-4A1A-800D-16B906426E71Q47100076-9A3EB2A4-27C6-4B5A-BB87-C56B4436C37DQ47118154-5F213B02-3CC7-4B1F-BD9D-099109F60CECQ47131393-3CCFC9AF-2707-4CD1-B5FB-3B9F9E9C184BQ47830761-78F6F31F-F9DF-4252-89C6-D985E532752CQ47926329-3CA16A8B-661C-4184-9121-6F793EFA973CQ58603625-3A55DCB6-93BB-4532-A38F-52D345564B3DQ58694197-9BAE0E7F-B895-4053-97C2-1A64A199DCA6
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmaco-miR: linking microRNAs and drug effects.
@ast
Pharmaco-miR: linking microRNAs and drug effects.
@en
type
label
Pharmaco-miR: linking microRNAs and drug effects.
@ast
Pharmaco-miR: linking microRNAs and drug effects.
@en
prefLabel
Pharmaco-miR: linking microRNAs and drug effects.
@ast
Pharmaco-miR: linking microRNAs and drug effects.
@en
P2093
P2860
P356
P1476
Pharmaco-miR: linking microRNAs and drug effects.
@en
P2093
Ishai Jaffe
Jakob Lewin Rukov
Jeppe Vinther
Noam Shomron
Roni Wilentzik
P2860
P304
P356
10.1093/BIB/BBS082
P577
2013-01-31T00:00:00Z